FDA warns public against unregistered tirzepatide product
The regulator flagged a tirzepatide product sold without registration, citing risks to consumers.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 12 05:22 ETSource: SunStar Publishing Inc.
The wire
- 01The FDA issued a public warning about an unregistered tirzepatide product.
- 02Unapproved GLP-1 products carry safety and quality risks for consumers buying outside legitimate channels.
- 03The source excerpt does not identify the seller or enforcement next steps.
From the source
Read at news.google.comFDA warns public against unregistered tirzepatide product